OTCMKTS:CRLBF

Cresco Labs Competitors

$12.17

+0.33 (+2.79 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

$11.52

Now: $12.17▼

$12.37

50-Day Range

$11.41

MA: $13.20▼

$15.50

52-Week Range

$3.00

Now: $12.17▼

$17.49

Volume736,192 shs

Average Volume1.42 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Cresco Labs (OTCMKTS:CRLBF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying CRLBF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Cresco Labs, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Cresco Labs vs. Abacus Health Products Stock

Abacus Health Products (OTCMKTS:ABAHF) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings.

Profitability

This table compares Abacus Health Products and Cresco Labs' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Abacus Health Products	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A

Valuation and Earnings

This table compares Abacus Health Products and Cresco Labs' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abacus Health Products	N/A	N/A	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings for Abacus Health Products and Cresco Labs, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abacus Health Products	0	0	0	0	N/A
Cresco Labs	0	1	7	0	2.88

Cresco Labs has a consensus target price of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, analysts clearly believe Cresco Labs is more favorable than Abacus Health Products.

Summary

Cresco Labs beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Cresco Labs vs. Acreage Stock

Acreage (OTCMKTS:ACRGF) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Acreage and Cresco Labs' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acreage	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A

Valuation & Earnings

This table compares Acreage and Cresco Labs' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acreage	N/A	N/A	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and target prices for Acreage and Cresco Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acreage	0	1	2	0	2.67
Cresco Labs	0	1	7	0	2.88

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Cresco Labs has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Acreage's higher possible upside, equities analysts clearly believe Acreage is more favorable than Cresco Labs.

Summary

Cresco Labs beats Acreage on 2 of the 3 factors compared between the two stocks.

Cresco Labs vs. Applied Biosciences Stock

Applied Biosciences (OTCMKTS:APPB) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Applied Biosciences and Cresco Labs' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Applied Biosciences	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and target prices for Applied Biosciences and Cresco Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Biosciences	0	0	0	0	N/A
Cresco Labs	0	1	7	0	2.88

Cresco Labs has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, analysts clearly believe Cresco Labs is more favorable than Applied Biosciences.

Valuation & Earnings

This table compares Applied Biosciences and Cresco Labs' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Biosciences	N/A	N/A	N/A	N/A	N/A
Cresco Labs	N/A	N/A	N/A	N/A	N/A

Summary

Cresco Labs beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Cresco Labs vs. Ayr Strategies Stock

Cresco Labs (OTCMKTS:CRLBF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Cresco Labs and Ayr Strategies' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	N/A	N/A	N/A
Ayr Strategies	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Cresco Labs and Ayr Strategies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	1	7	0	2.88
Ayr Strategies	0	1	6	0	2.86

Cresco Labs currently has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Cresco Labs.

Valuation and Earnings

This table compares Cresco Labs and Ayr Strategies' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	N/A	N/A	N/A	N/A	N/A
Ayr Strategies	N/A	N/A	N/A	N/A	N/A

Summary

Cresco Labs beats Ayr Strategies on 2 of the 3 factors compared between the two stocks.

Cresco Labs vs. Can B Stock

Cresco Labs (OTCMKTS:CRLBF) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Cresco Labs and Can B's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	N/A	N/A	N/A
Can B	N/A	N/A	N/A

Valuation and Earnings

This table compares Cresco Labs and Can B's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	N/A	N/A	N/A	N/A	N/A
Can B	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Cresco Labs and Can B, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	1	7	0	2.88
Can B	0	0	0	0	N/A

Cresco Labs currently has a consensus price target of $19.2125, indicating a potential upside of 57.90%. Given Cresco Labs' higher possible upside, equities research analysts plainly believe Cresco Labs is more favorable than Can B.

Summary

Cresco Labs beats Can B on 2 of the 2 factors compared between the two stocks.

Cresco Labs vs. Cansortium Stock

Cresco Labs (OTCMKTS:CRLBF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Cresco Labs and Cansortium's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	N/A	N/A	N/A
Cansortium	N/A	N/A	N/A

Earnings & Valuation

This table compares Cresco Labs and Cansortium's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	N/A	N/A	N/A	N/A	N/A
Cansortium	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Cresco Labs and Cansortium, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	1	7	0	2.88
Cansortium	0	0	1	0	3.00

Cresco Labs presently has a consensus target price of $19.2125, indicating a potential upside of 57.90%. Cansortium has a consensus target price of $1.20, indicating a potential upside of 18.81%. Given Cresco Labs' higher possible upside, analysts plainly believe Cresco Labs is more favorable than Cansortium.

Summary

Cresco Labs beats Cansortium on 2 of the 3 factors compared between the two stocks.